Advanced Search
Contact | Corporate | Help

A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Sponsors:
  • Hoffmann-La Roche
Phases:
  • Phase III
IndicationsAcronym:
  • Rheumatoid Arthritis
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: tocilizumab [RoActemra/Actemra]
  • Drug: methotrexate
  • Drug: methotrexate
  • Drug: placebo
Enrollment:
258

Additional information about NCT01399697.


SourceSolution © 2008-2012